Thus, we hypothesized that we could regulate EMT by regulation of PlncRNA-1 at the gene level in prostate cancers to improve the prognosis of prostate cancer patients and provide new interventions for their treatment. The gene discussed is CBR3-AS1; the disease is prostate carcinoma.